Clinical Trial Update: An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial assessing recombinant interleukin-2 in HIV-positive patients on antiretroviral therapy has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• recombinant interleukin-2 (interleukin-2)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2011-04-25